Summary
0HF3 Chart
Nittetsu Mining Provides $1.5 Million Fifth Earn-in Payment for Camino's Los Chapitos Project
VANCOUVER, BC / ACCESS Newswire / June 5, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the receipt of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to fully fund the upcoming exploration and drilling campaign at Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru.
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs
Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment points to continued demand for the healthcare supplies and niche specialty drugs Cencora can distribute. Future share price targets point to significant potential upside over 3 years, justifying a buy despite the stock trading above average now.
Cencora Inc. Dividends
 0HF3 3 months ago | Other | $0.55 Per Share |
| 0HF3 6 months ago | Other | $0.55 Per Share |
| 0HF3 10 months ago | Other | $0.51 Per Share |
| 0HF3 9 May 2024 | Other | $0.51 Per Share |
| 0HF3 8 Feb 2024 | Other | $0.51 Per Share |
Cencora Inc. Earnings
| 29 Jul 2025 (47 Days) Date | | - Cons. EPS | - EPS |
| 7 May 2025 Date | | - Cons. EPS | 3.68 EPS |
| 29 Apr 2025 Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 0HF3 3 months ago | Other | $0.55 Per Share |
| 0HF3 6 months ago | Other | $0.55 Per Share |
| 0HF3 10 months ago | Other | $0.51 Per Share |
| 0HF3 9 May 2024 | Other | $0.51 Per Share |
| 0HF3 8 Feb 2024 | Other | $0.51 Per Share |
| 29 Jul 2025 (47 Days) Date | | - Cons. EPS | - EPS |
| 7 May 2025 Date | | - Cons. EPS | 3.68 EPS |
| 29 Apr 2025 Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
Cencora Inc. (0HF3) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Cencora Inc. ever had a stock split?
Cencora Inc. Profile
| Medical - Distribution Industry | Healthcare Sector | Dr. Robert P. Mauch Ph.D., PharmD CEO | LSE Exchange | US03073E1055 ISIN |
| US Country | 42,000 Employees | 14 Feb 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Overview
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
Products and Services
U.S. Healthcare Solutions:
- Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
- Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
- Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
- Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
- Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
- Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.
International Healthcare Solutions:
- Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
- Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
- Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.
Contact Information
